Gardnerella vaginalis inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity or growth of the bacterium Gardnerella vaginalis. This bacterium is a primary component of the vaginal microbiota imbalance and is often associated with altered conditions in the vaginal environment. Inhibitors targeting G. vaginalis typically work by disrupting various aspects of the bacterium's biological processes, including cell wall synthesis, metabolic pathways, or mechanisms crucial for its adherence to host cells. By targeting these specific pathways, these inhibitors can prevent G. vaginalis from proliferating, disrupting its ability to colonize and interact within its niche effectively. The chemical structures of these inhibitors are varied, often encompassing a range of small molecules, peptides, and sometimes macromolecular entities, designed to interact with different biological targets associated with the bacterium.
The development of Gardnerella vaginalis inhibitors often involves screening for selective activity against the bacterium without affecting other members of the microbiota, ensuring that their action is specific. This specificity is crucial for preserving the balance of the normal vaginal microbiome while selectively targeting G. vaginalis. These inhibitors may exhibit a variety of chemical functionalities, which can range from hydroxyl, carboxyl, or amino groups that facilitate binding to G. vaginalis-specific targets, to more complex molecular moieties that provide stability and efficacy in different biological environments. Structural optimization of these molecules is a significant focus to enhance their specificity, stability, and bioavailability, while also mitigating potential off-target effects. As a result, the chemical diversity and mechanisms of action of Gardnerella vaginalis inhibitors make them an important focus of research for understanding the bacterium's role within the microbiome and the molecular interactions necessary for its survival and growth.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metronidazole | 443-48-1 | sc-204805 sc-204805A | 5 g 25 g | $84.00 $205.00 | 11 | |
Metronidazole can cause lethal DNA strand breaks within Gardnerella vaginalis cells, leading to a decrease in bacterial replication and a subsequent reduction in gene expression related to virulence and survival. | ||||||
Clindamycin | 18323-44-9 | sc-337636A sc-337636B sc-337636C sc-337636 | 25 mg 50 mg 100 mg 1 g | $156.00 $374.00 $572.00 $825.00 | 2 | |
Clindamycin may bind selectively to the 50S ribosomal subunit of Gardnerella vaginalis, resulting in the inhibition of peptide chain initiation and causing a decrease in the synthesis of essential proteins. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide can oxidize cellular components, leading to the inhibition of cellular processes and reducing the expression levels of key genes in Gardnerella vaginalis. | ||||||
Chlorhexidine | 55-56-1 | sc-252568 | 5 g | $103.00 | 3 | |
Chlorhexidine may cause precipitation of cytoplasmic constituents within Gardnerella vaginalis, leading to a reduction in cellular function and inhibition of gene expression necessary for bacterial replication. | ||||||
Boric Acid | 10043-35-3 | sc-202083B sc-202083 sc-202083C sc-202083A sc-202083D | 50 g 500 g 1 kg 2.5 kg 5 kg | $37.00 $78.00 $122.00 $176.00 $316.00 | 10 | |
Boric acid could inhibit the growth of Gardnerella vaginalis by destabilizing the enzymes involved in metabolism and DNA replication, leading to the downregulation of gene expression. | ||||||